Cargando…

Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma

BACKGROUND: The aim of this research was to evaluate clinical and low-cost genetic determinants of treatment outcome in EGFR mutation positive advanced lung adenocarcinoma patients. MATERIAL AND METHODS: EGFR mutation testing and EGFR 181946C>T genotyping were performed in 101 advanced lung adeno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jokic, Vera, Savic-Vujovic, Katarina, Spasic, Jelena, Bukumiric, Zoran, Marinkovic, Mladen, Radosavljevic, Davorin, Cavic, Milena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358214/ https://www.ncbi.nlm.nih.gov/pubmed/35958274 http://dx.doi.org/10.1177/15593258221117354

Ejemplares similares

Correlation of Ionized Magnesium with the Parameters of Oxidative Stress as Potential Biomarkers in Patients with Anxiety and Depression: A Pilot Study
por: Opanković, Ana, et al.
Publicado: (2022)

Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer
por: Spasic, Jelena, et al.
Publicado: (2022)

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021)

Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report
por: Jovanovic, Dragana, et al.
Publicado: (2017)

Hyoid Bone and Thyroid Cartilage Metastases from Sigmoid Colon Adenocarcinoma: A Case Report
por: Bracanovic, Djurdja, et al.
Publicado: (2017)

The Role of Haematological Parameters in Predicting the Response To Radical Chemoradiotherapy in Patients with Anal Squamous Cell Cancer
por: Stojanovic-Rundic, Suzana, et al.
Publicado: (2021)

Peripheral White Blood Cell Subsets in Metastatic Colorectal Cancer Patients Treated with Cetuximab: The Potential Clinical Relevance
por: Matić, Ivana Z., et al.
Publicado: (2018)

EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia
por: Vukovic, Miodrag, et al.
Publicado: (2023)

Assessing Attitudes towards Statistics among Medical Students: Psychometric Properties of the Serbian Version of the Survey of Attitudes Towards Statistics (SATS)
por: Stanisavljevic, Dejana, et al.
Publicado: (2014)

Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients
por: Marinkovic, Mladen, et al.
Publicado: (2022)

Association between right ventricle two- and three-dimensional echocardiography and exercise capacity in patients with reduced left ventricular ejection fraction
por: Sljivic, Aleksandra, et al.
Publicado: (2018)

COVID-19 and Cutaneous Squamous Cell Carcinoma—Impact of the Pandemic on Unequal Access to Healthcare
por: Jović, Marko, et al.
Publicado: (2023)

Factors affecting the development of adverse drug reactions to β-blockers in hospitalized cardiac patient population
por: Mugoša, Snežana, et al.
Publicado: (2016)

The Coming-Out of Malaria Gametocytes
por: Kuehn, Andrea, et al.
Publicado: (2010)

Metastasis of Prostate Adenocarcinoma to the Testis
por: Campara, Zoran, et al.
Publicado: (2016)

Improving Education in Medical Statistics: Implementing a Blended Learning Model in the Existing Curriculum
por: Milic, Natasa M., et al.
Publicado: (2016)

Recording blood pressure and eGFR in primary care after the Belgrade screening study
por: Lezaic, Visnja, et al.
Publicado: (2018)

Evaluation of different formulas for LDL-C calculation
por: Vujovic, Ana, et al.
Publicado: (2010)

KRAS and EGFR mutations coexisting in lung adenocarcinoma
por: Sousa, Vitor, et al.
Publicado: (2010)

EGFR unusual mutation status in lung adenocarcinomas
por: Alarcão, Ana, et al.
Publicado: (2010)

EGFR and KRAS Mutations in Patients With Adenocarcinoma of the Lung
por: Jang, Tae Won, et al.
Publicado: (2009)

Get out! And don't come back!
por: Wells, William A.
Publicado: (2004)

Thrombotic Events Develop in 1 Out of 5 Patients Receiving ECMO Support: An 11-Year Referral Centre Experience
por: Rajsic, Sasa, et al.
Publicado: (2023)

Clinicopathological features and relation between anaplastic lymphoma kinase (ALK) mutation and histological subtype of lung adenocarcinoma in Eastern European Caucasian population
por: Zaric, Bojan, et al.
Publicado: (2016)

DOK2 Inhibits EGFR-Mutated Lung Adenocarcinoma
por: Berger, Alice H., et al.
Publicado: (2013)

The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas
por: Cho, Jaeyoung, et al.
Publicado: (2016)

EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
por: Tseng, Chien-Hua, et al.
Publicado: (2017)

Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer
por: Pavlovic, Mladen, et al.
Publicado: (2018)

High frequency traders come out of the shadows
por: McTague, Jim, et al.
Publicado: (2011)

Sofosbuvir Has Come Out of the Magic Box
por: Alavian, Seyed Moayed
Publicado: (2013)

Coming out: the experience of LGBT+ people in STEM
por: Barres, Ben, et al.
Publicado: (2017)

Editorial: The World Coming Out of Its Shell
por: Scypinski, Stephen
Publicado: (2021)

Coming Out of Nowhere: The Paradox of the Birth of Omicron
por: Mortazavi, Seyed Alireza, et al.
Publicado: (2022)

The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
por: Chung, Fu-Tsai, et al.
Publicado: (2015)

KIF5B-EGFR Fusion: A Novel EGFR Mutation in Lung Adenocarcinoma
por: Xu, Hui, et al.
Publicado: (2020)

Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases
por: Shi, Liang, et al.
Publicado: (2021)

Coming Out to Doctors, Coming Out to “Everyone”: Understanding the Average Sequence of Transgender Identity Disclosures Using Social Media Data
por: Haimson, Oliver L., et al.
Publicado: (2020)

Identification of EGFR Mutations by Immunohistochemistry with EGFR Mutation–Specific Antibodies in Biopsy and Resection Specimens from Pulmonary Adenocarcinoma
por: Kim, Chi Hong, et al.
Publicado: (2015)

Predicting EGFR Mutation in Lung Adenocarcinoma: Development and Validation of the EGFR Mutation Predictive Score (EMPS) in Bali, Indonesia
por: Njoto, Edwin Nugroho, et al.
Publicado: (2023)

Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Marinkovic, Mladen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lrn0h39r2vtmhq7jg3pqg5a1lq